Anhui Sunhere Pharmaceutical Excipients Co Ltd
SZSE:300452
Intrinsic Value
Anhui Sunhere Pharmaceutical Excipients Co., Ltd. engages in the research, development, production, and sale of pharmaceutical excipients. [ Read More ]
The intrinsic value of one Anhui Sunhere Pharmaceutical Excipients Co Ltd stock under the Base Case scenario is 16.68 CNY. Compared to the current market price of 13.03 CNY, Anhui Sunhere Pharmaceutical Excipients Co Ltd is Undervalued by 22%.
Valuation Backtest
Anhui Sunhere Pharmaceutical Excipients Co Ltd
Run backtest to discover the historical profit from buying and selling Anhui Sunhere Pharmaceutical Excipients Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
This note will be permanently deleted.
Balance Sheet Decomposition
Anhui Sunhere Pharmaceutical Excipients Co Ltd
| Current Assets | 939.4m |
| Cash & Short-Term Investments | 661.9m |
| Receivables | 152m |
| Other Current Assets | 125.5m |
| Non-Current Assets | 603.3m |
| PP&E | 504.3m |
| Intangibles | 91.5m |
| Other Non-Current Assets | 7.6m |
| Current Liabilities | 273.4m |
| Accounts Payable | 105.2m |
| Accrued Liabilities | 18.6m |
| Short-Term Debt | 136.8m |
| Other Current Liabilities | 12.8m |
| Non-Current Liabilities | 403.3m |
| Long-Term Debt | 287.6m |
| Other Non-Current Liabilities | 115.7m |
Earnings Waterfall
Anhui Sunhere Pharmaceutical Excipients Co Ltd
|
Revenue
|
829.2m
CNY
|
|
Cost of Revenue
|
-572.1m
CNY
|
|
Gross Profit
|
257.2m
CNY
|
|
Operating Expenses
|
-88.8m
CNY
|
|
Operating Income
|
168.3m
CNY
|
|
Other Expenses
|
-6.4m
CNY
|
|
Net Income
|
162m
CNY
|
Free Cash Flow Analysis
Anhui Sunhere Pharmaceutical Excipients Co Ltd
| CNY | |
| Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Anhui Sunhere Pharmaceutical Excipients Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Anhui Sunhere Pharmaceutical Excipients Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Anhui Sunhere Pharmaceutical Excipients Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
Anhui Sunhere Pharmaceutical Excipients Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Anhui Sunhere Pharmaceutical Excipients Co Ltd
According to Wall Street analysts, the average 1-year price target for Anhui Sunhere Pharmaceutical Excipients Co Ltd is 18.36 CNY with a low forecast of 18.18 CNY and a high forecast of 18.9 CNY.
Shareholder Return
Price
Anhui Sunhere Pharmaceutical Excipients Co Ltd
| Average Annual Return | 19.18% |
| Standard Deviation of Annual Returns | 23.25% |
| Max Drawdown | -56% |
| Market Capitalization | 3B CNY |
| Shares Outstanding | 234 439 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Anhui Sunhere Pharmaceutical Excipients Co., Ltd. engages in the research, development, production, and sale of pharmaceutical excipients. The company is headquartered in Huainan, Anhui and currently employs 885 full-time employees. The company went IPO on 2015-05-15. is principally engaged in the research and development, production and distribution of pharmaceutical excipients. Its major products include cellulose microciystalline, esium stearate, carboxymethyl starch sodium, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, film coating powder, carboxymethylcellulose sodium, medicinal dextrin, medicinal starch and silicon dioxide, among others. Its products are mainly used in the production of filler, adhesive, disintegrating agent, lubricating agent and coating materials, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one Anhui Sunhere Pharmaceutical Excipients Co Ltd stock under the Base Case scenario is 16.68 CNY.
Compared to the current market price of 13.03 CNY, Anhui Sunhere Pharmaceutical Excipients Co Ltd is Undervalued by 22%.
You don't have any saved screeners yet
